Regenxbio Inc - 80% of Patients Who Received Pivotal Dose Discontinued Intravenous Enzyme Replacement Therapy or Remained Treatment-Naïve
Regenxbio公司 - 收到關鍵劑量的80%患者停止靜脈酶替代治療或保持治療原始狀態
Regenxbio Inc - 80% of Patients Who Received Pivotal Dose Discontinued Intravenous Enzyme Replacement Therapy or Remained Treatment-Naïve
Regenxbio公司 - 收到關鍵劑量的80%患者停止靜脈酶替代治療或保持治療原始狀態
譯文內容由第三人軟體翻譯。